Biopreservation Media Providers Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of biopreservation media providers was valued at USD 850.1 million in 2023, and a CAGR of 23.1% is expected during the forecast period. Growing demand for organ transplants with a rising number of chronic disease patients. Rising healthcare expenditure in the countries by the government is driving growth in the market significantly. Increasing use of stem cell therapies, tissue engineering, and gene therapies requires effective biopreservation media for storage and transportation of cells and tissues. High cost of equipment and stability issues are posing challenge in the market growth. Biopreservation media typically contains cryoprotectants like DSMO, serum, or serum free formulations to prevent cell-damage during freezing.

Growing investment in biobanks for preserving biospecimen is driving growth in the market significantly. Pharmaceuticals, and Biotech companies are heavily investing in research that relies on sample preservation. High cost of media, and storage solutions and risk of contamination, and loss of sample viability over time is driving growth in the market. Increasing demand for serum-free, and chemically defined media for enhancing safety, and efficacy is driving growth in the market significantly. Expansion of precision medicine, and increased focus on long term sample viability is driving growth in the market.

Growth in clinical trials and FDA approvals for regenerative medicine is accelerating market expansion. Increasing demand for biobanks for storing biological samples such as DNA, RNA, proteins, and cell lines for research and therapeutic applications is driving growth in the market. Increasing emphasis on personalized medicine has led to higher demand for biobanked samples, driving bio preservation media usage.

Growth Drivers

Increasing incidence of chronic diseases like Cancer, and Diabetes has increased the need for biobanking of tissues, and cell for research and therapeutic purposes. Demand for organ transplantation has increased significantly, leading to higher usage of preservation media for donor organs and tissues. Startups focusing on biopreservation technology and regenerative medicine are driving innovation in media formulations and applications. Collaboration between startups and established players are enhancing market dynamics. Pharmaceutical companies rely on biopreservation for maintaining the quality of biological materials during drug discovery and development processes. Integration of automation, and AI in biopreservation protocols improves efficiency and scalability.

Rapid development of cell-based therapies for cancer, autoimmune diseases, and rare diseases necessitates robust preservation techniques. Increasing emphasis on personalized medicine has led to higher demand for biobanked samples. Advancements in biobanks are also crucial for the growth in the market. Increasing use of stem cell therapies, tissue engineering, and gene therapies requires effective biopreservation media for storage and transportation of cells and tissues.

Segmentation

By Product

·         Equipment

o   Freezers

o   Refrigerators

o   Consumables

·         Liquid Nitrogen

o   Media

o   Pre-formulated

o   Home-brew

By Application

·         Regenerative Medicine

o   Cell Therapy

o   Gene Therapy

o   Others

·         Biobanking

o   Human eggs

o   Human sperms

o   Veterinary IVF

o   Drug Discovery

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Bio preservation Media Providers Market by Application

On the basis of the application, the bio preservation media providers market is segmented into regenerative medicine and biobanking. Biobanking is the leading segment in the market; it involves the storage of biological samples like blood, cells, and tissues for future research or therapeutic use, making it crucial in areas like genomics, personalized medicine, and disease studies.

Increased investment in biobanks by government, academic institutions, and pharmaceutical companies drives the demand in the market significantly. Regenerative medicine is a fast-growing application; its adoption of bio preservation media is more specialized. It's essential for preserving stem cells, tissues, and engineered products, but it is far behind biobanking in terms of revenue. Advancement in organ transplantation and stem cell technology is driving growth in the market.

Growth in clinical trials and FDA approvals for regenerative medicine is accelerating market expansion. Increasing demand for biobanks for storing biological samples such as DNA, RNA, proteins, and cell lines for research and therapeutic applications is driving growth in the market. Drug discovery in development in all over the world is driving growth in the market significantly.

 Regional Outlook

On the basis of the regions, the bio preservation media providers market is segmented into 5 parts: Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. The North America region is currently the leading segment in the bio preservation media providers market. Due to well-established health infrastructure and high investment in research and development, especially in biotechnology, pharmaceuticals are driving growth in the market significantly. Growing demand for regenerative and precision medicines is a key factor behind the market growth.

The Asia Pacific region is just second to North America, and increasing investment in biobanking, rising healthcare expenditure, and a large number of people suffering due to chronic diseases like kidney and liver disease are driving growth in the market significantly. Rapid development of cell-based therapy for efficient treatment of cancer and increasing number of biobanks are driving the demand in the market significantly.

Europe has well-established biopharma and biotech industries, with countries like Germany, the UK, and France housing numerous research facilities and biotech companies. Significant funding from government bodies and private investors supports life sciences research, including regenerative medicine and stem cell therapy. Collaboration between academia and industries accelerates innovation in bio-preservation techniques. Several global leaders in the market, like Merck, have a strong presence in Europe.

An increasing geriatric population is more chronic disease prone, and increasing demand for regenerative medicine and organ transplantation relies on bio preservation technologies. The growing prevalence of chronic diseases like liver and kidney diseases is driving growth in the market. Europe has advanced infrastructure for cold chain logistics, essential for the storage and transportation of bio preservation media. Increasing focus on sustainability and eco-friendly bio-preservative methods, aligning with regional policies and consumer preferences. Presence of key players in North America, and European countries are driving growth in the market.

Key Players

·         Thermo Fisher Scientific Inc.

·         ThermoGenesis Holdings Inc.

·         Bio-Techne Corporation

·         BioLife Solutions Inc.

·         Sortorius AG

·         Merck KgaA

·         PHC Holdings Corporation

·         Azenta Inc.

·         Cryoport Inc.

·         Other Players